| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 01/16/2003 | CA2450236A1 Phage displayed pdz domain ligands |
| 01/16/2003 | CA2450185A1 Use of a tyrosine recombinase for genetic engineering |
| 01/16/2003 | CA2450020A1 Dna sequences comprising gene transcription regulatory qualities and methods for detecting and using dna sequences |
| 01/16/2003 | CA2443644A1 Genetic analysis of peyers's patches and m cells and methods and compositions targeting peyer's patches and m cell receptors |
| 01/15/2003 | EP1275965A1 Method for identifying substances which modulate interleukin 4 (IL-4) signaling |
| 01/15/2003 | EP1275738A1 Method for random cDNA synthesis and amplification |
| 01/15/2003 | EP1275737A2 Compositions and processes for analyte detection; quantification and amplification |
| 01/15/2003 | EP1275736A1 Method for detection of frameshift mutations |
| 01/15/2003 | EP1275735A1 Composition and method for hot start nucleic acid amplification |
| 01/15/2003 | EP1275734A1 Method for random cDNA synthesis and amplification |
| 01/15/2003 | EP1275733A2 Assay methods for peptidase modulators |
| 01/15/2003 | EP1275729A1 Process for producing l-amino acid via fermentation method |
| 01/15/2003 | EP1275728A1 Polyhydroxyalkanoate-containing structure and manufacturing method thereof |
| 01/15/2003 | EP1275725A1 Use of the nucleotide sequence of the lactobacillus casei lactose operon promoter for regulating gene expression by means of an antiterminator protein |
| 01/15/2003 | EP1275723A1 Recombinant D-hydantoin hydrolases and N-carbamyl-D-amino acid hydrolases, and DNA encoding them; uses thereof for producing D-amino acids |
| 01/15/2003 | EP1275722A1 A P387L variant in protein tyrosine phosphatase-1B is associated with type 2 diabetes and impaired serine phosphorylation of PTP-1B in vitro |
| 01/15/2003 | EP1275721A1 Alpha 1,4-n-acetylgalactosamine transferase gene and process for producing this enzyme and n-acetylgalactosamine-containing complex carbohydrate |
| 01/15/2003 | EP1275720A2 Histidyl-trna synthetase of staphylococcus aureus |
| 01/15/2003 | EP1275719A1 Gene concerning brassinosteroid-sensitivity of plants and utilization thereof |
| 01/15/2003 | EP1275718A2 TCF mutant |
| 01/15/2003 | EP1275717A1 Proliferative glomerular nephritis-associated gene |
| 01/15/2003 | EP1275716A2 Modified DNA molecule, recombinant containing the same thing, and uses thereof |
| 01/15/2003 | EP1275711A1 Lipase/acyltransferase from Candida parapsilosis |
| 01/15/2003 | EP1275659A1 Novel physiologically active peptides and use thereof |
| 01/15/2003 | EP1275438A2 Containers for performing polymerase chain reaction |
| 01/15/2003 | EP1275002A1 Method for linking nucleic acids and/or glycosaminoglycans to polar/hydrophilic materials |
| 01/15/2003 | EP1274986A1 Device and method for determining multiple analytes |
| 01/15/2003 | EP1274866A2 Diagnosis of diseases associated with metastasis |
| 01/15/2003 | EP1274865A2 Diagnosis of diseases associated with apoptosis by means of assessing the methylation status of genes associated with apoptosis |
| 01/15/2003 | EP1274864A2 Genetic testing for determining the risk of pouchitis development |
| 01/15/2003 | EP1274862A1 Control of a gene induced by oxidized lipids in human artery wall cells |
| 01/15/2003 | EP1274861A1 Compositions and methods for identifying and targeting cancer cells |
| 01/15/2003 | EP1274859A1 Specific peptide substrate for human yak1, yak3a, and yak3b and yeast yak1 protein kinases |
| 01/15/2003 | EP1274857A1 Inhibitor of differentiation knockout mammals and methods of use thereof |
| 01/15/2003 | EP1274855A1 Method for the production of cotton somatic embryos |
| 01/15/2003 | EP1274854A2 Self-extinguishing recombinases, nucleic acids encoding them and methods of using the same |
| 01/15/2003 | EP1274853A1 Materials and methods relating to immune responses to fusion proteins |
| 01/15/2003 | EP1274852A2 Targeted vaccine delivery systems |
| 01/15/2003 | EP1274851A1 A nucleic acid construct encoding a processing component derived from the n-terminal region of the hepatitis virus orf2, and an antigenic polypeptide |
| 01/15/2003 | EP1274850A2 Nucleic acid sequences to proteins involved in tocopherol synthesis |
| 01/15/2003 | EP1274849A2 Protein phosphatases |
| 01/15/2003 | EP1274848A2 Mre11 orthologue and uses thereof |
| 01/15/2003 | EP1274846A2 Plastid transformation vectors for expressing human proteins in plants |
| 01/15/2003 | EP1274845A2 Lipid binding protein 3 |
| 01/15/2003 | EP1274844A2 G-protein coupled receptors and nucleic acids encoding same |
| 01/15/2003 | EP1274843A1 New lipid binding protein 2 |
| 01/15/2003 | EP1274842A2 Lipid binding protein 4 |
| 01/15/2003 | EP1274841A2 Regulation of human cyslt2-like gpcr protein |
| 01/15/2003 | EP1274840A2 Ligand for herpes simplex virus entry mediator and methods of use |
| 01/15/2003 | EP1274839A2 A p-selectin glycoprotein ligand (psgl-1) binding protein and uses therefor |
| 01/15/2003 | EP1274838A1 Synthetic internal ribosome entry sites and methods of identifying the same |
| 01/15/2003 | EP1274837A2 Apparatus and method for separating and purifying polynucleotides |
| 01/15/2003 | EP1274836A1 Lactic acid bacteria overproducing exopolysaccharides |
| 01/15/2003 | EP1274835A1 Human nim1 kinase |
| 01/15/2003 | EP1274834A1 HUMAN AMINOACYL-tRNA SYNTHETASE POLYPEPTIDES USEFUL FOR THE REGULATION OF ANGIOGENESIS |
| 01/15/2003 | EP1274831A2 Polynucleotides encoding novel secreted proteins |
| 01/15/2003 | EP1274745A1 Magnetic, silanised polyvinylalcohol-basedcarrier materials |
| 01/15/2003 | EP1274731A1 Human hepatocyte growth factor activator inhibitor homologue |
| 01/15/2003 | EP1274730A2 Integrin/adhesion antagonists |
| 01/15/2003 | EP1274729A2 G protein coupled receptor |
| 01/15/2003 | EP1274728A2 Methods and compositions for the prevention and treatment of anemia |
| 01/15/2003 | EP1274727A1 Nk-2 homeobox transcription factor |
| 01/15/2003 | EP1274726A2 Therapeutic compounds and methods for modulating v3, a versican isoform |
| 01/15/2003 | EP1274720A1 Albumin fusion proteins |
| 01/15/2003 | EP1274719A2 Albumin fusion proteins |
| 01/15/2003 | EP1274661A1 Polymer coated surfaces for microarray applications |
| 01/15/2003 | EP1274510A2 Purification apparatus and method |
| 01/15/2003 | EP1274464A2 Compositions and methods for regulated protein expression in gut |
| 01/15/2003 | EP1274462A2 Targeted transfection of cells using a biotinylated dendrimer |
| 01/15/2003 | EP1274451A1 Sperm factor oscillogenin |
| 01/15/2003 | EP1274307A2 Hr-elicitors to inhibit postharvest disease or desiccation of fruits or vegetables |
| 01/15/2003 | EP1274305A2 Aids ancestral viruses and vaccines |
| 01/15/2003 | EP1173611A4 Methods for determination of single nucleic acid polymorphisms using a bioelectronic microchip |
| 01/15/2003 | EP1171635A4 Electronically mediated nucleic acid amplification in nasba |
| 01/15/2003 | EP1159603A4 Raman optrode processes and devices for detection of chemicals and microorganisms |
| 01/15/2003 | EP1157105A4 Regulatory constructs comprising intron 3 of prostate specific membrane antigen gene |
| 01/15/2003 | EP1071765A4 Alk-1 responds to tgf-beta and signals through smad-1 and smad-5 |
| 01/15/2003 | EP1034302A4 De novo or "universal" sequencing array |
| 01/15/2003 | EP1015627A4 Method for detecting a target compound using a nucleic acid ligand |
| 01/15/2003 | EP0984833B1 Device for selectively filtering under reduced pressure and for vacuum drying sample liquids or drops of sample liquids as well as use of said device |
| 01/15/2003 | EP0979235A4 Isolated nucleic acid molecule coding for tumor rejection antigen precursors mage-c1 and mage-c2 and uses thereof |
| 01/15/2003 | EP0958376A4 Prolactin receptor gene as a genetic marker for increased litter size in pigs |
| 01/15/2003 | EP0954222A4 Gene therapy for proliferative vitreoretinopathy |
| 01/15/2003 | EP0833659A4 Therapeutic fragments of von willebrand factor |
| 01/15/2003 | EP0815235B1 Vaccines for plague |
| 01/15/2003 | EP0781349B1 Decomposition of bacteria cells by phage lysins |
| 01/15/2003 | EP0751986B1 Method for increasing plasmid yield |
| 01/15/2003 | EP0749981B1 Monoclonal antibody specific for pd-ecgf / thymidine phosphorylase |
| 01/15/2003 | EP0671927B1 Human neutralizing monoclonal antibodies to respiratory syncytial virus |
| 01/15/2003 | EP0667920B1 Methods of detecting micrometastasis of prostate cancer |
| 01/15/2003 | CN1391616A Process for labeling ribonucleic acid and labeled RNA fragments obtained thereby |
| 01/15/2003 | CN1391615A Dna测序方法 Dna sequencing methods |
| 01/15/2003 | CN1391612A Thermophilic amino acid biosynthesis system enzyme gene of thermotolerant coryneform bacterium |
| 01/15/2003 | CN1391611A Novel phenol oxidizing enzymes |
| 01/15/2003 | CN1391610A BASB118 polypeptide and polynucleotide from moraxella catarrhalis |
| 01/15/2003 | CN1391609A Use of replication-deficient adenoviral vector to boost CD8+T cell immune response to antigen |
| 01/15/2003 | CN1391608A Cloning, expression and characterisation of gene expressed in tumour cells and involved in regulation of immune response |
| 01/15/2003 | CN1391605A Gynogenetic or androgenetic production of pluripotent cells and cell lines, and use thereof to produce differentiated cells and tissues |
| 01/15/2003 | CN1391581A Endogenous and non-endogenous versions of human G protein-coupled receptors |
| 01/15/2003 | CN1391579A HEV antigenic peptide and its method |